Dania Therapeutics ApS

Dania Tx is a biotech company developing small molecule drugs to treat Acute Myeloid Leukaemia (AML) and other cancers. Our focus is on targeting a new biological mechanism regulating metabolism, thereby exploiting the fact that metabolism in cancer cells differs from that in normal cells. This broad-acting mechanism of action holds the potential for the treatment to be used across many cancer types.

Contact name:

Karin Absalonsen, co-founder and chairperson


Sundvænget 36, 2900 Hellerup





Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact ps@danskbiotek.dk or +45 7172 1114

Copyright 2024 DANISH BIO – DANSK BIOTEK. All rights reserved.